Dr. Mayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana Farber Cancer Institute, D-1608
Boston, MA 02215Phone+1 617-632-3474Fax+1 617-632-2260
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1969 - 1971
Harvard Medical SchoolClass of 1969
Certifications & Licensure
NY State Medical License 1970 - Present
MA State Medical License 1974 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
- Super Doctor SuperDoctors.com
Clinical Trials
- SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Start of enrollment: 1994 Mar 01
- S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed Start of enrollment: 1994 Dec 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 303 citationsImpact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer A Pooled AnalysisLeonard L. Gunderson, Daniel J. Sargent, Joel E. Tepper, Norman Wolmark, Michael J. O'Connell
Journal of Clinical Oncology. 2004-05-15 - 85 citationsNCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020.Dawn Provenzale, Reid M. Ness, Xavier Llor, Jennifer M. Weiss, Benjamin Abbadessa
Journal of the National Comprehensive Cancer Network. 2020-10-01 - 243 citationsInfluence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinomaJeffrey A. Meyerhardt, Paul J. Catalano, Daniel G. Haller, Robert J. Mayer, Al B. Benson
Cancer. 2003-08-01
Press Mentions
In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology ProgramSeptember 8th, 2022- Dan Hayes Witnessed Cancer History, Now He Is Documenting It in a PodcastJune 4th, 2021
Adjuvant FOLFIRINOX Gives Big Boost to Pancreatic Ca SurvivalDecember 19th, 2018- Join now to see all
Grant Support
- Graduate Training In Cancer ResearchNational Cancer Institute1990–2011
- Bladder Permeability Of FluoresceinNational Center For Research Resources2005
- Clinical Oncology Research Career Development ProgramNational Cancer Institute1992–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
